| Literature DB >> 29045710 |
Christopher Wilke1, David Grosshans1, Joseph Duman1, Paul Brown1, Jing Li1.
Abstract
Radiotherapy is ubiquitous in the treatment of patients with both primary brain tumors as well as disease which is metastatic to the brain. This therapy is not without cost, however, as cognitive decline is frequently associated with cranial radiation, particularly with whole brain radiotherapy (WBRT). The precise mechanisms responsible for radiation-induced morbidity remain incompletely understood and continue to be an active area of ongoing research. In this article, we review the hypothetical means by which cranial radiation induces cognitive decline as well as potential therapeutic approaches to prevent, minimize, or reverse treatment-induced cognitive deterioration. We additionally review advances in imaging modalities that can potentially be used to identify site-specific radiation-induced anatomic or functional changes in the brain and their correlation with clinical outcomes.Entities:
Mesh:
Year: 2018 PMID: 29045710 PMCID: PMC5892147 DOI: 10.1093/neuonc/nox195
Source DB: PubMed Journal: Neuro Oncol ISSN: 1522-8517 Impact factor: 12.300